Just Other Articles
#1 in Business Subscribe Email Print

You are here: Home > Business > Accounting > Introduction to Financial Accounting and GAAP

Tags

  • management
  • advantages
  • should
  • combination products
  • shareholders equity

  • Links

  • Questions and Answers About Social Security, Car Payments, and Budgeting An Irregular Income
  • How To Create Your Own Emergency Fund
  • Real Estate Agents Weak in Providing Fiduciary Duties
  • Just Other Articles - Introduction to Financial Accounting and GAAP

    Accounting, a.k.a. “The Language of Business”, is a large and diverse topic. Subtopics include financial accounting, cost accounting, management accountin
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    g, internal auditing external auditing, international accounting, governmental and not-for-profit accounting and taxes. The subtopic that comprises the la
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    gest portion of an accountants academic program of study is financial accounting.

    The purpose of financial accounting is basically to provide useful infor
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ation to users who will use that information to make a decision, most commonly either an investment or a credit decision. To be useful information needs t
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    be relevant and reliable. The most common means of conveying information to users is through the preparation of financial statements: 1. the income stat
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ment, 2. the balance sheet, 3. the statement of cash flows, and 4. the statement of shareholders’ equity.

    The income statement presents the profitability
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    f company over a period of time. The balance sheet presents the assets, liabilities, and owners’ equity at the end of the period of time used for the inco
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    e statement. The statement of cash flows classifies all cash inflows and outflows during the time period into one of three categories: operating, investi
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    g, and financing. The statement of shareholders’ equity shows how the shareholders’ equity changed over the period.

    Generally accepted accounting princip
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    es (GAAP) are a set of standards, methods, procedures, and guidelines companies follow in measuring and reporting financial information in the financial st
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    tements. GAAP comes from written sources as well as practices that have been used for a ling time that have become generally accepted. Although the Secur
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ties and Exchange Commission (SEC) has the legal authority to set accounting standards for companies, it has always delegated the majority of this responsi
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ility to the accounting profession itself. The current accounting professional body that sets standards is known as the Financial Accounting Standards Boa
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    d (FASB). The FASB issues standards called Statements of Financial Accounting Standards (SFAS). They can be found on the FASB web-site, www.fasb.org. As
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    of May 2007 the FASB has issued 159 such statements.

    All publicly traded companies listing their stocks on U.S. stock exchanges must have their financial
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    tatement audited by an external CPA firm that expresses an opinion as to whether the financial statements have been prepared in conformity with GAAP. The
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    dea is to lend credibility to the financial statements by providing a third-party’s verification that the statements are presented fairly in conformity wit
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    high quality standards, GAAP!

    Recent accounting scandals (WorldCom, Enron, etc), however, have given the accounting profession somewhat of a black eye an
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    have rekindled the debate over whether principles-based, or more recently termed, objectives-oriented, standards should be set forth as opposed to rules-b
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    sed accounting standards. A principles-based approach to standard setting stresses professional judgment, as opposed to following a specific list of rules


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.justotherarticles.org.ua/article/5297/justotherarticles-Introduction-to-Financial-Accounting-and-GAAP.html">Introduction to Financial Accounting and GAAP</a>

    BB link (for phorums):
    [url=http://www.justotherarticles.org.ua/article/5297/justotherarticles-Introduction-to-Financial-Accounting-and-GAAP.html]Introduction to Financial Accounting and GAAP[/url]

    Related Articles:

    How to Be a Great Client

    Managing The E-mail Monster

    What to Do If...Help Your Cleaning Staff Know What to Do in Certain Situations

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com